04

In a profile of Dr. Melody Campbell, she described her structural biology work as fun: “It’s always really rewarding to get a structure where you can see exactly where molecules are in relation to each other.”

Dr. Tina Termini explained how her NIH-funded research helps people: "We are searching for better treatments for patients who have already succumbed to cancer who are already suffering from cancer.”

Dr. Jesse Bloom commented on how rapidly SARS-CoV-2, the virus that causes COVID, evolves: "The speed at which it's undergone that evolution and the ability it's shown to undergo these big evolutionary jumps is really remarkable."

Dr. Tom Lynch discussed how federal funding impacts cancer research: “Cancer research is done with federal funding, which is why the potential reduction in federal funding for science is so incredibly threatening to science throughout the country.”

Dr. Masumi Ueda Oshima explained a clinical trial at Fred Hutch to prevent chronic GVHD. She said, “We think this regimen deserves further study in a multicenter fashion, and we are exploring some potential opportunities for that.”

Dr. Rachel Issaka and Fred Hutch patient Natalie Phelps discussed early onset colorectal cancer. Issaka said, “The number of people diagnosed in 1994 compared to 2024 has now doubled.” 

Dr. Phuong Vo explained clinical findings that could expand transplant access for people without a fully matched unrelated donor: “The patients experienced low incidence of GVHD, with no instances of severe chronic GVHD reported.”